References
- Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Haematol 2000;7:358–363.
- Majumdar MK, Thidee MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematoth Stem Cell 2000;9:841–848.
- Campana D, Manabe A, Evans WE. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 1993;7:482–488.
- Chu E, DeVita VT. Physicians' cancer chemotherapy drug manual 2006. Sudbury, Mass: Jones and Bartlett; 2006. pp 51–54.
- Richards N, Kilberg M. Asparagine synthetase chemotherapy. Annu Rev Biochem 2006;75:629–654.
- Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007;117:1049–1057.
- Avramis VI, Sencer S, Periclou AP, et al A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 2002;99:1986–1994.
- Mauer AM. Therapy of acute lymphoblastic leukemia in childhood. Blood 1980;56:1–10.
- Li J, Law. H., Lau YL, Chan GC. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 2004;127:326–334.
- Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, Bornhäuser M. Inhibition of platelet-derived growth factor receptor-beta by IM suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 2007;40:355–366.
- Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E, Campana D. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 2003;120:846–849.
- Peng B, Hayes M, Resta D, et al Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients. J Clin Oncol 2004;22:935–942.
- van den Berg HW, Desai ZT, Wilson R, Kennedy G, Birdges JM, Shanks RG. The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination. Cancer Chemother Pharmacol 1982;8:215–219.
- Groninger E, Koopmans P, Kamps W, de Graaf S, Uges D. An automated HPLC method to determine intracellular vincristine concentrations in mononuclear cells of children with acute lymphoblastic leukemia. Ther Drug Monit 2003;25:441–446.
- Mueller LP, Luetzkendorf J, Mueller T, Reichelt K, Simon H, Schmoll HJ. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction. Stem Cells 2003;24:2753–2765.